The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
2010 · Cancer Cell · 590 citations
https://doi.org/10.1016/j.ccr.2010.06.014
Z
Zhujun Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
922
Citations
10
h-index
10
i10-index
Zhujun Jiang is an academic researcher. The author has contributed to research in topics: Drug Solubulity and Delivery Systems & Cancer Immunotherapy and Biomarkers & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 10, co-authored 16 publications.
Papers by this author
worksEffective Anti-Neu–Initiated Antitumor Responses Require the Complex Role of CD4+ T Cells
2013 · Clinical Cancer Research · 64 citations
https://doi.org/10.1158/1078-0432.ccr-12-2522
A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation
2024 · Nature Communications · 42 citations
https://doi.org/10.1038/s41467-024-46130-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat